Emapta Secures COVID-19 Vaccine for All Employees
Moderna vaccine to be administered to staff for free as early as Q2 onwards.
MANILA, Philippines – Australian-owned outsourcing company, Emapta, announced that, together with its client partners, it has finalised the pre-order of 7,000 Moderna vaccines for its 3,500 employees in the Philippines. The company secured the earliest available vaccines to ramp up its COVID-19 response plan with the first batch of vaccines to be administered as early as Q2.
Emapta will provide both rounds of vaccines without any charges to all 3,500 employees in its 14 offices located all over Metro Manila, Baguio and Pampanga.
“We are determined to safeguard the wellbeing of our staff against the COVID-19 virus,” Emapta CEO and Founder Tim Vorbach said. “Procuring a legitimate and proven vaccine for our people early and at no cost is the best way to protect them at present.”
The vaccine rollout program is the latest addition to Emapta’s pandemic response initiatives designed to help employees cope during these trying times. The recently launched online Emapta COVID-19 vaccine hub will also serve as the central communications platform to update staff with its vaccine rollout progress.
Since the onset of the pandemic and declaration of Enhanced Community Quarantine (ECQ) in the Philippines last March 2020, Emapta and its client partners were quick to mobilise its team to work from home while its cybersecurity department implemented bank-level security protocols organisation-wide. Emapta’s 14 offices spread across the Philippines remained fully operational and continues to serve employees as part of its business continuity procedures.
Emapta also supported employees who have been displaced by the pandemic through talent reassignment programs as well as applying them for the Department of Labour and Employment (DOLE)’s COVID-19 Adjustment Measures Program (CAMP).
“Right from the start, we have implemented strict health protocols in our offices and even helped our staff transition to remote work arrangements to keep them safe,” says Inge Zwick, Executive Director at Emapta. “There’s no doubt that the vaccine would have a tremendous impact on their physical safety and psychological wellbeing, easing their worries and keeping everyone around them safe from COVID-19, too.”